Quince Therapeutics Inc

NASDAQ:QNCX 4:00:00 PM EDT

1.06

-0.05 (-4.50%)

4:00:47 PM EDT: $1.03 -0.03 (-2.83%)

Quince Therapeutics Inc Stock, NASDAQ:QNCX

611 Gateway Boulevard, Suite 273, South San Francisco, California 94080

United States of America

Phone: +1.650.910.5717

Number of Employees: 32

http://quincetx.com

Description

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.